Amolyt Pharma is a biotechnology company focused on developing peptide therapeutics for rare endocrine and metabolic diseases. Its lead program, eneboparatide, is being developed…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Amolyt →Already a subscriber? Sign in
Xcout Intel tracks Amolyt continuously — this profile deepens as new filings, funding, people and hiring data arrive.